software graphpad prism version 8.0 for windows (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
software graphpad prism version 8.0 for windows
Software Graphpad Prism Version 8.0 For Windows, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+software+graphpad+prism+version+8%2E0+for+windows/graphpad+prism+software/10__1590_slash_2175___8239___jbn___2024___0015en-116-10-16
Average 90 stars, based on 1 article reviews
Software Graphpad Prism Version 8.0 For Windows, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+software+graphpad+prism+version+8%2E0+for+windows/graphpad+prism+software/10__1590_slash_2175___8239___jbn___2024___0015en-116-10-16
Average 90 stars, based on 1 article reviews
software graphpad prism version 8.0 for windows - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Software:Article Title: The evolutionary conserved miR-137/325 tandem mediates obesity-induced hypogonadism and metabolic comorbidities by repressing hypothalamic kisspeptin. Article Snippet: Background: Obesity-induced hypogonadism (OIH) is a prevalent, but often neglected condition in men, which aggravates the metabolic complications of overweight.. While hypothalamic suppression of Kiss1-encoded kisspeptin has been suggested to contribute to OIH, the molecular mechanisms for such repression in obesity, and the therapeutic implications thereof, remain unknown.. Methods: A combination of bioinformatic, expression and functional analyses was implemented, assessing the role of the evolutionary-conserved miRNAs, miR-137 and miR-325, in mediating obesity-induced suppression of hypothalamic kisspeptin, as putative mechanism of central hypogonadism and metabolic comorbidities. |